998056_515738608494989_261353558_n

Merck improves manufacturing program

October 13, 2015
Manufacturing and Production Merck, Merck Millipore, manufacturing, production

Merck Millipore, the life science business arm of Merck KGaA, has introduced enhancements to its Emprove portfolio of raw pharmaceutical …

lilly_entrance_web

Lilly shares fall as company abandons evacetrapib development

October 13, 2015
Manufacturing and Production evacetrapib, high cholesterol, lilly, phase III, phase III failure

Eli Lilly shares fell by nearly 8% this week as the company announced it will abandon developmenty of the investigational …

afinitor_logo

Blow for Scottish women as SMC rejects Afinitor for advanced breast cancer

October 12, 2015
Sales and Marketing SMC, advanced breast cancer

The Scottish Medicines Consortium (SMC) has announced that it will not recommend Novartis’s Afinitor (everolimus) for use in advanced breast …

zytiga

New cancer medicines approved in Scotland, available via NHS

October 12, 2015
Sales and Marketing Scottish Medicines Consortium, Zytiga, abiraterone acetate, prostate cancer

The Scottish Medicines Consortium (SMC) has today recommended Janssen’s Zytiga (abiraterone acetate) for use before chemotherapy in men with advanced …

abpi_logo

Health professionals back transparency of their dealings with pharma

October 12, 2015
Research and Development, Sales and Marketing ABPI, transparency

The majority of doctors, nurses, hospital specialists and pharmacists believe that payments received by healthcare professionals (HCPs) from pharmaceutical companies …

think_big_on_genomics_research

Time for pharma to think big on genomics research

October 12, 2015
Research and Development Sir John Chisholm, genomics

Sir John Chisholm, executive chair of Genomics England, is very clear about what the project he is overseeing is – …

FDA sign

Obama’s FDA nominee criticised for big pharma ties

October 12, 2015
Sales and Marketing Bernie Sanders, Dr Robert Califf, FDA

Democratic presidential nomination candidate Senator Bernie Sanders has criticised President Obama’s choice for the next FDA commissioner, as a result …

Pfizer logo

Pfizer wins Zoloft birth defects lawsuit

October 12, 2015
Sales and Marketing Pfizer, Zoloft, birth defects, lawsuits, sertraline

Judges in the US have dismissed a lawsuit against Pfizer that had claimed that the use of its antidepressant Zoloft during pregnancy …

keytruda3-web

MSD’s Keytruda receives green light from NICE for NHS use

October 12, 2015
Sales and Marketing MSD, Merck, NICE, keytruda, melanoma, pembrolizumab, skin cancer

The UK healthcare watchdog NICE has recommended Keytruda as a treatment for advanced skin cancer – its second endorsement of …

Psoriasis

Novartis psoriasis drug shows three-year efficacy

October 12, 2015
Cosentyx, EADV, Novartis, Secukinumab, psoriasis

Novartis has announced new trial data confirming the efficacy of Cosentyx in patients with moderate-to-severe plaque psoriasis. The results of …

gsk_offices_in_rio_de_janeiro

How can pharma succeed in emerging markets?

October 10, 2015
Sales and Marketing GSK, Pfizer

In recent years, the major pharma companies have been forced to react to the maturation and cost-cutting, plus regulatory pressures, …

biogen_logo

Biogen reports on Tecfidera multiple sclerosis clinical trials

October 9, 2015
Research and Development

Biogen has presented data demonstrating the efficacy and safety of Tecfidera (dimethyl fumarate) across a broad range of people with …

sativex

Almirall presents new data on cannabinoid-based MS treatment

October 9, 2015
Research and Development Almirall, multiple sclerosis

Almirall has presented new clinical evidences of Sativex, the only medicine derived from cannabinoids to treat spasticity symptoms in MS, …

guido_rasi

EMA appoints Guido Rasi as executive director

October 9, 2015
Medical Communications, Sales and Marketing EMA, Guido Rasi

The European Medicines Agency’s (EMA’s) Management Board has nominated Professor Guido Rasi as the Executive Director of the Agency. The …

money_pills

Oncology groups and doctors fight for lower-priced cancer treatments

October 9, 2015
Medical Communications, Research and Development, Sales and Marketing

Oncology groups such as the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) are working …

sanofi_olivier_brandicourt

Sanofi looks to increase productivity in France by 25%

October 9, 2015
Manufacturing and Production, Medical Communications Sanofi

Sanofi is looking for a deal with unions in order to boost productivity by 20-25% at French plants over three …

merckincweb2

Merck announces positive Elbasvir/Grazoprevir trial results

October 9, 2015
Research and Development

Merck has announced the publication of results from C-SURFER, the first Phase III clinical trial to investigate an all-oral, ribavirin-free …

astrazeneca_plaque

AstraZeneca’s Moventig now available through NHS

October 9, 2015
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, moventig

AstraZeneca has announced that Moventig (naloxegol) has been made available for adult patients with opioid-induced constipation (OIC) in England and …

bronchial_thermoplasty

Taking on IFP, COPD and severe asthma: ERS 2015 roundup

October 9, 2015
Medical Communications, Research and Development

Leading pharmaceutical companies, physicians, healthcare professionals, scientists, respiratory experts, and of course the media, including Pharmafocus, gathered in Amsterdam at the …

dr_jerome_b_zeldis

Ovid Therapeutics appoints Dr Jerome B. Zeldis to Its Scientific Advisory Board

October 9, 2015
Medical Communications

Ovid Therapeutics, a privately held biopharmaceutical company focused on developing therapies for rare and orphan diseases of the brain, has …

The Gateway to Local Adoption Series

Latest content